Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications

Figure 1

Schematic overview of stem cell therapy in diabetic complications. AGEs: advanced glycated end products; EPCs: epithelial progenitor cells; MSC: mesenchymal stromal cells; HSCs: hematopoietic stem cells; ADSC: adipose-derived stem cells; ESCs: embryonic stem cells; iPSCs: induced pluripotent stem cells.